| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | Oct 2, 2025 | Monopar Therapeutics | COO | Sell | 42.5 | -1,896 | -3.78% | ✗ | $154.8K |
| Jun 30, 2025 | Jul 2, 2025 | Monopar Therapeutics | COO | Sell | 42.5 | -2,990 | -6.12% | ✗ | $107K |
| Mar 31, 2025 | Apr 2, 2025 | Monopar Therapeutics | COO | Sell | 46.3 | -744 | -1.74% | ✗ | $27.1K |
| Dec 31, 2024 | Jan 2, 2025 | Monopar Therapeutics | COO | Sell | 46.3 | -721 | -1.73% | ✗ | $15.9K |
| Sep 30, 2024 | Oct 2, 2024 | Monopar Therapeutics | COO | Sell | 47.5 | -535 | -1.32% | ✗ | $3.6K |
| Jun 30, 2024 | Jul 2, 2024 | Monopar Therapeutics | COO | Sell | 47.5 | -2,019 | -1.03% | ✗ | $1.5K |
| Jun 18, 2024 | Jun 21, 2024 | Monopar Therapeutics | COO | Buy | 91.3 | +32,508 | 21.16% | ✗ | $25.6K |
| Jun 13, 2024 | Jun 17, 2024 | Monopar Therapeutics | COO | Buy | 91.3 | +36,000 | 30.61% | ✗ | $32.9K |
| Jun 3, 2024 | Jun 5, 2024 | Monopar Therapeutics | COO | Buy | 91.3 | +24,000 | 25.63% | ✗ | $18.5K |
| May 29, 2024 | May 31, 2024 | Monopar Therapeutics | COO | Buy | 91.3 | +36,000 | 62.47% | ✗ | $23.1K |
| Mar 31, 2024 | Apr 2, 2024 | Monopar Therapeutics | COO | Sell | 47.5 | -3,098 | -5.10% | ✗ | $2.1K |
| Dec 31, 2023 | Jan 3, 2024 | Monopar Therapeutics | COO | Sell | 47.5 | -3,098 | -5.65% | ✗ | $1.1K |
| Sep 30, 2023 | Oct 3, 2023 | Monopar Therapeutics | COO | Sell | 47.5 | -2,624 | -5.41% | ✗ | $1.6K |
| Jun 30, 2023 | Jul 3, 2023 | Monopar Therapeutics | COO | Sell | 47.5 | -4,057 | -9.30% | ✗ | $3.5K |
| Mar 31, 2023 | Apr 4, 2023 | Monopar Therapeutics | COO | Sell | 47.5 | -1,154 | -3.73% | ✗ | $1.6K |
| Dec 31, 2022 | Jan 3, 2023 | Monopar Therapeutics | COO | Sell | 27.5 | -1,406 | -4.97% | ✗ | $3.3K |
| Nov 14, 2022 | Nov 16, 2022 | Monopar Therapeutics | COO | Buy | 91.3 | +16,053 | 196.13% | ✗ | $49.7K |
| Sep 30, 2022 | Oct 3, 2022 | Monopar Therapeutics | COO | Sell | 27.5 | -1,191 | -12.70% | ✗ | $1.8K |
| Jun 30, 2022 | Jul 1, 2022 | Monopar Therapeutics | COO | Sell | 27.5 | -2,812 | -34.61% | ✗ | $6.5K |